Drug Type Monoclonal antibody |
Synonyms PBI 204, PBI204 |
Target |
Mechanism ADM inhibitors(adrenomedullin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sepsis | Preclinical | US | 09 Oct 2023 |